Andrew Hoffman focuses his practice on representing pharmaceutical manufacturers and other life sciences companies in government investigations and related litigation. 

He defends clients facing inquiries by Main Justice, the Securities and Exchange Commission, US Attorney's Offices, State Attorneys General and municipal entities. He also represents clients facing whistleblower lawsuits brought under federal and state false claims laws. 

Andrew has extensive experience conducting internal investigations relating to potential violations of US health care laws, FDA regulations and corporate policies. His experience includes investigating potential data integrity concerns and other GMP issues at U.S. and international manufacturing sites.

He regularly conducts proactive risk assessments and provides clients with advice and analysis to help them mitigate the significant risks posed by the current enforcement and litigation environment.